ArticleTargeted oncology2024

Modelling the Effectiveness of Tepotinib in Comparison to Standard-of-Care Treatments in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harbouring METex14 Skipping in the UK.

Rachael Batteson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.